welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
New treatment reduces precancerous polyps in hereditary cancer patients
Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.
expertly curated content related to this topic
-
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysisObjective The benefits of pancreatic ...
-
Chemoprevention of Colorectal NeoplasiaBACKGROUND : Colorectal cancer is a comm...
-
Clinical End Points for Developing Pharmaceuticals to Manage Patients with a Sporadic or Genetic Risk of Colorectal ...To reduce the morbidity and mortality fr...
-
Chemoprevention in Lynch SyndromeCAPP1 tested aspirin 600 mg/day and/or r...
-
Chemoprevention of Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) has...
-
Cleveland ClinicCleveland Clinic is the largest private ...
-
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal AnastomosesThe primary purpose of this prospective,...